事关新疫苗纳入免疫规划，这一国家级专家组织名单首次官宣

Core Viewpoint - The transparency and scientific basis of China's immunization policy are expected to improve with the recent adjustments to the National Immunization Planning Expert Advisory Committee, which has expanded its membership and publicly disclosed its members for the first time since its establishment in 2017 [3][4]. Group 1: Expert Committee Adjustments - The National Immunization Planning Expert Advisory Committee has been expanded from 27 to 30 members, with a diverse range of experts from fields such as epidemiology, clinical medicine, and immunology [3][5]. - The new committee's term remains three years, and the updated regulations emphasize that committee members must not have direct interests with vaccine license holders to ensure decision-making independence [4][6]. Group 2: Committee's Role and Responsibilities - The core function of the committee is to provide evidence-based recommendations on vaccine usage and immunization strategies, including the introduction and adjustment of vaccines, immunization strategy optimization, and cost-effectiveness evaluations [5][6]. - The inclusion of experts from the fiscal and taxation fields in the new committee is significant, as it relates to health equity and public financial expenditure [5]. Group 3: Expert Profiles - The committee is chaired by Wang Junzhi, an academician with extensive experience in vaccine regulation and bio-products [6]. - Notable members include academicians Gao Fu and Xia Ning Shao, who have significant contributions to vaccine development and public health [6]. Group 4: Future Recommendations - Public health scholars suggest that the committee should adopt international best practices by establishing a regular information release system to enhance transparency and reduce vaccine hesitancy, ultimately improving national immunization coverage [7].